BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 18393293)

  • 1. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin.
    Komuta M; Spee B; Vander Borght S; De Vos R; Verslype C; Aerts R; Yano H; Suzuki T; Matsuda M; Fujii H; Desmet VJ; Kojiro M; Roskams T
    Hepatology; 2008 May; 47(5):1544-56. PubMed ID: 18393293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined hepatocellular-cholangiocarcinoma (cholangiolocellular type) with stem-cell features: a clinicopathologic analysis of 26 cases].
    Xu J; Zhang C; Qiao A; Xi Y
    Zhonghua Bing Li Xue Za Zhi; 2016 Mar; 45(3):175-9. PubMed ID: 26956962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of multidrug resistance-associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin.
    Vander Borght S; Komuta M; Libbrecht L; Katoonizadeh A; Aerts R; Dymarkowski S; Verslype C; Nevens F; Roskams T
    Liver Int; 2008 Dec; 28(10):1370-80. PubMed ID: 19055643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes.
    Komuta M; Govaere O; Vandecaveye V; Akiba J; Van Steenbergen W; Verslype C; Laleman W; Pirenne J; Aerts R; Yano H; Nevens F; Topal B; Roskams T
    Hepatology; 2012 Jun; 55(6):1876-88. PubMed ID: 22271564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
    Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
    Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic study on cholangiolocellular carcinoma.
    Shiota K; Taguchi J; Nakashima O; Nakashima M; Kojiro M
    Oncol Rep; 2001; 8(2):263-8. PubMed ID: 11182037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence.
    Zhang F; Chen XP; Zhang W; Dong HH; Xiang S; Zhang WG; Zhang BX
    Histopathology; 2008 Jan; 52(2):224-32. PubMed ID: 18184271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma.
    Cai X; Xiong J; Hu QG; Zhao QD; Wu D; Tang LG; Wan CD; Wei LX
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):873-879. PubMed ID: 29270746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma.
    Roskams T
    Oncogene; 2006 Jun; 25(27):3818-22. PubMed ID: 16799623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of hepatic stem/progenitor cells in canine hepatocellular and cholangiocellular carcinoma.
    Cogliati B; Aloia TP; Bosch RV; Alves VA; Hernandez-Blazquez FJ; Dagli ML
    Vet Comp Oncol; 2010 Jun; 8(2):112-21. PubMed ID: 20579324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'.
    Kozaka K; Sasaki M; Fujii T; Harada K; Zen Y; Sato Y; Sawada S; Minato H; Matsui O; Nakanuma Y
    Histopathology; 2007 Sep; 51(3):390-400. PubMed ID: 17553067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance of 'subtypes with stem-cell feature' in combined hepatocellular-cholangiocarcinoma.
    Sasaki M; Sato H; Kakuda Y; Sato Y; Choi JH; Nakanuma Y
    Liver Int; 2015 Mar; 35(3):1024-35. PubMed ID: 24712771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
    Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
    J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrahepatic cholangiocarcinoma arising in chronic advanced liver disease and the cholangiocarcinomatous component of hepatocellular cholangiocarcinoma share common phenotypes and cholangiocarcinogenesis.
    Xu J; Sasaki M; Harada K; Sato Y; Ikeda H; Kim JH; Yu E; Nakanuma Y
    Histopathology; 2011 Dec; 59(6):1090-9. PubMed ID: 22175889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma.
    Xiao SY; Wang HL; Hart J; Fleming D; Beard MR
    Am J Pathol; 2001 Oct; 159(4):1415-21. PubMed ID: 11583969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic recurrence of cholangiolocellular carcinoma: report of a case.
    Yamamoto M; Takasaki K; Nakano M; Saito A
    Hepatogastroenterology; 1996; 43(10):1046-50. PubMed ID: 8884337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic clear cell cholangiocarcinoma: immunohistochemical aspects in a very rare type of cholangiocarcinoma.
    Haas S; Gütgemann I; Wolff M; Fischer HP
    Am J Surg Pathol; 2007 Jun; 31(6):902-6. PubMed ID: 17527078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial cell adhesion molecule-positive human hepatic neoplastic cells: development of combined hepatocellular-cholangiocarcinoma in mice.
    Ogasawara S; Akiba J; Nakayama M; Nakashima O; Torimura T; Yano H
    J Gastroenterol Hepatol; 2015 Feb; 30(2):413-20. PubMed ID: 25087473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition.
    Seok JY; Na DC; Woo HG; Roncalli M; Kwon SM; Yoo JE; Ahn EY; Kim GI; Choi JS; Kim YB; Park YN
    Hepatology; 2012 Jun; 55(6):1776-86. PubMed ID: 22234953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of an alpha-fetoprotein-producing intrahepatic cholangiocarcinoma suggests probable cancer stem cell origin.
    Ishikawa K; Sasaki A; Haraguchi N; Yoshikawa Y; Mori M
    Oncologist; 2007 Mar; 12(3):320-4. PubMed ID: 17405896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.